For US Healthcare Professionals
I am a
Crohn’s Disease Specialist
Once a decision has been made to prescribe TREMFYA® for moderately to severely active Crohn’s disease
For commercially insured, eligible patients with moderately to severely active Crohn’s disease
Start tremfya® WITH CONFIDENCE
Eligible patients can receive their first subcutaneous induction trial dose through TREMFYA withMe in as fast as 1 day*
1
Send
a completed Patient Enrollment Form (PEF) to TREMFYA withMe through FAX/eFAX
2
START in as fast as 1 day
Eligible patients receive the first SC induction trial dose of TREMFYA® at no cost:
Commercially insured
≥18 years old
Moderately to severely active Crohn’s disease
For Trial, no delay or denial required
PATIENTS MUST ANSWER PHONE CALL FROM “J&J WITHME” 888-796-8152
3
Stay
After the trial dose, you may continue the patient’s treatment:
If payer policy is not updated for Crohn’s disease, or if coverage is delayed or denied, through the TREMFYA withMe Access Program for eligible patients†
If payer policy is updated, via the specialty pharmacy by submitting 1 PA for SC induction and maintenance doses‡
Eligible commercial patients with a delay or denial in coverage can receive TREMFYA® in as fast as 3 days for up to 3 years through the TREMFYA withMe Access Program†
Induction Dosing
1
Submit
a Patient Enrollment Form
(PEF) to TREMFYA withMe with both the IV induction and SC maintenance information complete via FAX/eFAX
2
Acquire
product via Specialty Distributor or via TREMFYA withMe Access Program for eligible patients
3
Schedule
first infusion
Maintenance Dosing
4
SUBMIT
the prior authorization for
SC maintenance
If commercially covered, product is shipped to patient via specialty pharmacy, or
Shipped via the TREMFYA withMe Access Program for eligible patients
FAX/eFAX the PEF to 800-600-7226.
Contact your Field Representative from Johnson & Johnson or call 844-494-8463 (8 AM – 8 PM ET) for more information.
The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA®.
TREMFYA withMe can help support eligible commercial patients to start and stay on TREMFYA®
Only one PA for SC induction & maintenance doses‡
STARTING ON TREMFYA®
Eligible patients can become familiar with TREMFYA® by receiving the initial SC induction dose through TREMFYA withMe in as fast as 1 day.*
Single-point enrollment across all TREMFYA withMe offerings
Patient support offerings
TREMFYA withMe Savings Program
Pay as little as $0 per dose, including certain administration and lab costs§
TREMFYA withMe Access Program
Receive medicine at no cost, if there is a delay or denial†
STAYING ON TREMFYA®
Comprehensive, impactful program with offerings designed to provide support throughout the patient journey, including a dedicated Nurse Guide||¶
||Nurse Guides do not provide medical advice.
¶Patient Authorization is required.
Patient resilience coaching may be available through a limited pilot program
For patients starting with IV induction, the TREMFYA withMe Access Program can help eligible commercial patients with a delay or denial in coverage receive TREMFYA® medicine at no cost in as fast as 3 days for up to 3 years
The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA®.
*See program requirements for the TREMFYA withMe Trial Offer at TREMFYAwithMeTrial.com.
†See program requirements for the TREMFYA withMe Access Program at TREMFYAwithMeAccess.com.
‡Individual patient coverage may vary.
§The TREMFYA withMe Savings Program consists of Medicine Cost Support and Treatment Administration Cost Support (includes eligible laboratory tests). Maximum program benefit per calendar year shall apply. Offer subject to change or end without notice. See program requirements at TREMFYAwithMeSavings.com.
IV=intravenous; PA=prior authorization; SC=subcutaneous.
ENROLLING PATIENTS
Initiate patient enrollment for TREMFYA withMe support and resources
To enroll your patients in TREMFYA withMe, complete the form below, then fax or eFax it to 800-600-7226.
The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA®.
Access & affordability
Support may be available
TREMFYA withMe SAVINGS PROGRAM
Pay
as little as
$0
per dose
Eligible commercial patients may
pay as little as $0 per dose.
Program consists of Medicine Cost Support and Treatment Administration Cost Support
TREMFYA withMe ACCESS PROGRAM
as fast as
3 days
for up to
3 years
For eligible commercial patients starting with IV induction who experience a delay of >5 business days or a denial of coverage, TREMFYA withMe offers TREMFYA® at no cost in as fast as 3 days and for up to 3 years or until insurance covers the medication.
THE TREMFYA withMe TEAM
One dedicated team with one goal
The TREMFYA withMe team works together to deliver customized fulfillment support for TREMFYA® patients.
Case Manager TEAM
Led by your Case Manager, the primary point of contact for the healthcare professional office. Highly trained across all programs and skilled at matching patients to the right support.
FIELD Reimbursement MANAGER (FRM)*
Provides in-office educational support and partners with your Case Manager Team to get eligible patients who have been prescribed TREMFYA® started on therapy as quickly as possible.
nurse guide†‡
Provides personalized support to answer questions and help patients navigate treatment.
The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA®.
*Protected Health Information cannot be exchanged without a Business Associate Agreement or Patient Authorization on file.
‡Protected Health Information cannot be exchanged without a Patient Authorization on file.
ENHANCED OFFERINGS FOR PATIENTS STARTING WITH INFUSIONS
Infusion services for a streamlined patient-focused fulfillment experience
Once a decision has been made to prescribe TREMFYA®, TREMFYA withMe Infusion Services is intended to help patients start their 3 IV induction doses and transition to SC maintenance doses through a streamlined fulfillment experience.
TREMFYA withMe Infusion Services utilizes a contracted network of Infusion Service Providers (ISPs)* to coordinate continuity of care and support the overall patient experience by leveraging existing infrastructure and clinical expertise.
*The contracted ISPs are not the only ISPs available, and Janssen Biotech, Inc. does not endorse the use of any infusion service providers in particular. The information provided represents no statement, promise, or guarantee of Janssen Biotech, Inc., concerning levels of reimbursement, payment, or charge. Please consult specific payer organizations with regard to local or actual coverage, reimbursement policies, and determination processes.
The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA®.
If you have questions, call your Case Manager team at 844-494-8463, Monday−Friday, 8:00 AM – 8:00 PM ET. Multilingual phone support available.
Sign up or log in to the Provider Portal at Portal.JNJwithMe.com, where you can request and review benefits investigations, enroll eligible patients in the TREMFYA withMe Savings Program, and view Savings Program transactions as requested by the patient.
